Michael Wilkinson
@MWilkinsonMD
Followers
1K
Following
1K
Media
68
Statuses
450
Preventive cardiologist, lipidologist, and clinical researcher @UCSDHealth @UCSDMedSchool
Joined October 2014
🔥Immune-mediated inflammatory diseases & dyslipidemia intersect, drive CV risk. 🏃♀️💊Targeted prevention can make a difference. @DrMichaelShapir .@atvbahajournals . @garshick @Bweber04 @CBallantyneMD @DrMarthaGulati @JohnKastelein @mdavidsonmd @lipiddoc .
ahajournals.org
Individuals with autoimmune inflammatory diseases, such as systemic lupus erythematosus, rheumatoid arthritis, and psoriasis, are at increased risk for cardiovascular disease. While these diseases...
5
15
50
RT @nationallipid: 🎉Congratulations to our President & Chapter President Service Award winners!. Your dedication to the NLA drives our miss….
0
4
0
Thanks @MedJournal360 for the opportunity to discuss our real-world study of evinacumab in HoFH:. @MatthewIto @Priyeshabijlani @mdavidsonmd . @UCSDCardiology @nationallipid @ASPCardio @FamilyHeartFdn @PamTaubMD @CBallantyneMD @hillypaige2 @tmodarressi.
medjournal360.com
Excited to share our multisite, real-world US experience with evinacumab in HoFH @atvbahajournals . Generally well-tolerated & lowered LDL-C by ~50%, similar to trials. @MatthewIto @mdavidsonmd @Priyeshabijlani.
0
1
8
Representing @nationallipid at the SD Heart Failure Symposium - join your Pacific Lipid Association regional chapter! . 🔥Amazing opening session on #prevention with @PamTaubMD @hsbhatia @AntoinetteBirs @garymamd Anya Narezkina. Thank you, Dr. Barry Greenberg! @HFSA @ISHLT
1
3
25
➡️In @LipidJournal: real-world data, early experience with inclisiran @UCSDHealth @UCSDCardiology . Congrats @DMazdeyasnan, @AntoinetteBirs, @TommyTChiou . @PamTaubMD @ASPCardio @CBallantyneMD @DrMichaelShapir @tmodarressi @ArchnaBajajMD @Nishant_ShahMD .
1
7
24
RT @AJPCardio: @AJPCardio has earned a new impact factor of 5.9 and is now ranked 34 out of 230 journals in Cardiac & Cardiovascular System….
0
5
0
RT @UCSDCardiology: Announcing the launch of UC San Diego BEACON (Bioinformatics, Epidemiology, and Lp(a) Center for Research and InnOvatio….
today.ucsd.edu
UC San Diego has established the Bioinformatics, Epidemiology, and Lp(a) Center for Research and InnOvatioN (BEACON) to better understand how elevated Lp(a) levels contribute to heart disease with...
0
5
0
RT @PamTaubMD: We are excited to announce the launch of the UC San Diego BEACON (Bioinformatics, Epidemiology, and Lp(a) Center for Researc….
0
18
0
RT @nationallipid: 📅 1 week away! Join the next #NLAPracticalPearls webinar on June 12 at 12:30pm ET with @marstonMD: TG-Targets: ApoC3 & A….
0
1
0
RT @nationallipid: View and download the patient infographic for Multidisciplinary Teams in Clinical Lipidology and Cardiometabolic Care.⬇️.
0
3
0
RT @foundationofnla: Lipid management & cardiometabolic health require a team-based approach.🤝 Learn more about the resources available for….
0
6
0
RT @nationallipid: 📣In case you missed it at #NLASessions: The NLA released its Expert Clinical Review on Multidisciplinary Teams in Clinic….
0
13
0
Congratulations @nationallipid for such a fantastic meeting! Good to see you, @DrSafarova and thank you for your many contributions to 2025 #NLASessions.
@CBallantyneMD @nationallipid Wonderful meeting, friends and colleagues at #NLASessions #NLA2025 @EugeniaGianos @carolkirkpat3 @AAgarwalaMD @DineshKalra @dan_soffer @MWilkinsonMD
1
2
9
This was an excellent, clinically useful lecture with really interesting and educational cases, thank you @Dr_Zahid_Ahmad!. #NLASessions .@CBallantyneMD @lipiddoc @nationallipid @carolkirkpat3 @EugeniaGianos.
1
4
14
Congrats @dan_soffer, so well-deserved, thank you for all of your generous teaching and mentorship #NLASessions Also, congrats on becoming MNLA!. @nationallipid @CBallantyneMD @lipiddoc @ASPCardio @DrMichaelShapir @hsbhatia @MarlysLPA @EugeniaGianos @carolkirkpat3 @DineshKalra.
Congratulations @dan_soffer, a great mentor, colleague and friend, well-deserved! Sorry to have missed this part of NLA!.
0
0
15
Congrats to Dr. Cheeley & all co-authors on this practical, timely review on multidisciplinary teams - fantastic presentation by Dr. Cheely #NLASessions @nationallipid @carolkirkpat3 @VCUDPOSChair @CBallantyneMD @ASPCardio @UCSDCardiology.
0
5
16
Congrats @nationallipid #NLASessions on a fantastic opening session including incredible overview of CETPi by Dr. Ann Marie Navar, highlighting ⬇️Lp(a), plus past and current trials . @ProfKausikRay @MarlysLPA @CBallantyneMD @PamTaubMD @mdavidsonmd @JohnKastelein @hsbhatia
0
7
23
RT @hillypaige2: #KnowHoFH.Important, large analysis from @MWilkinsonMD and colleagues highlighting real world data on evinacumab.👏👏.@Famil….
0
1
0
@atvbahajournals @MatthewIto @mdavidsonmd @Priyeshabijlani @UCSDHealth @hsbhatia @DrNathanWong @loridanielsmd @VietHeartPA @ArchnaBajajMD @tmodarressi @NP_ltl_a @dansoffer @DrSafarova @FamilyHeartFdn @nationallipid @ASPCardio @CBallantyneMD @UCSDCardiology @PamTaubMD @DrMarthaGulati @DrMichaelShapir
3
3
16
Excited to share our multisite, real-world US experience with evinacumab in HoFH @atvbahajournals . Generally well-tolerated & lowered LDL-C by ~50%, similar to trials. @MatthewIto @mdavidsonmd @Priyeshabijlani.
ahajournals.org
BACKGROUND: Homozygous familial hypercholesterolemia (HoFH) is an autosomal semidominant disorder characterized by extreme elevations in LDL-C (low-density lipoprotein cholesterol) and early-onset...
3
5
24
Thanks, @carolkirkpat3 for moderating this webinar & thanks to all who attended #lipoproteina #lpa . Next up @marstonMD June 12, 2025 12:30 PM ET, ApoC3 & ANGPTL3. @nationallipid @foundationofnla @CBallantyneMD @PamTaubMD @hsbhatia @UCSDCardiology @TIMIStudyGroup @MassGenBrigham.
@MWilkinsonMD @nationallipid @foundationofnla @CBallantyneMD @MarlysLPA @PamTaubMD @hsbhatia @UCSDCardiology @UCSDHealth @DrMichaelShapir @DrMarthaGulati For those not able to join us but who are interested in the presentation, it is available to view here:
1
5
13